Quadrant Capital Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $117K | Hold |
8,396
| – | – | ﹤0.01% | 1440 |
|
|
2025
Q4 | $136K | Sell |
8,396
-480
| -5% | -$7.83K | ﹤0.01% | 1405 |
|
|
2025
Q3 | $133K | Buy |
+8,876
| New | +$108K | ﹤0.01% | 1403 |
|
|
2025
Q2 | – | Sell |
-9,635
| Closed | -$71.6K | – | 1352 |
|
|
2025
Q1 | $71.6K | Buy |
9,635
+759
| +9% | +$5.83K | ﹤0.01% | 1611 |
|
|
2024
Q4 | $53.2K | Hold |
8,876
| – | – | ﹤0.01% | 1378 |
|
|
2024
Q3 | $45.4K | Hold |
8,876
| – | – | ﹤0.01% | 1498 |
|
|
2024
Q2 | $32.1K | Buy |
8,876
+8,287
| +1,407% | +$26.3K | ﹤0.01% | 1638 |
|
|
2024
Q1 | $1.89K | Buy |
+589
| New | +$2.28K | ﹤0.01% | 2523 |
|
|
2023
Q4 | – | Sell |
-125
| Closed | -$682 | – | 2694 |
|
|
2023
Q3 | $682 | Sell |
125
-1,090
| -90% | -$7.21K | ﹤0.01% | 2530 |
|
|
2023
Q2 | $8.15K | Sell |
1,215
-343
| -22% | -$2.55K | ﹤0.01% | 2076 |
|
|
2023
Q1 | $13.8K | Buy |
1,558
+192
| +14% | +$1.69K | ﹤0.01% | 1880 |
|
|
2022
Q4 | $10.4K | Buy |
1,366
+201
| +17% | +$1.56K | ﹤0.01% | 1927 |
|
|
2022
Q3 | $8K | Sell |
1,165
-38
| -3% | -$358 | ﹤0.01% | 1948 |
|
|
2022
Q2 | $10K | Buy |
1,203
+432
| +56% | +$3.8K | ﹤0.01% | 1635 |
|
|
2022
Q1 | $10K | Buy |
+771
| New | +$12.1K | ﹤0.01% | 1625 |
|
|
2021
Q4 | – | Sell |
-7
| Closed | – | – | 2485 |
|
|
2021
Q3 | $0 | Buy |
+7
| New | +$253 | ﹤0.01% | 2479 |
|
|
2021
Q2 | – | Sell |
-5
| Closed | – | – | 2392 |
|
|
2021
Q1 | $0 | Buy |
5
+2
| +67% | +$108 | ﹤0.01% | 2374 |
|
|
2020
Q4 | $0 | Buy |
+3
| New | +$155 | ﹤0.01% | 2280 |
|
Other funds holding ADPT
VCM
VPM
